| Oct 7 |
Reasons to Retain QIAGEN Stock in Your Portfolio for Now
|
| Oct 1 |
QIAGEN Launches QIAcuityDx Digital PCR System: Stock to Gain?
|
| Sep 30 |
QIAGEN launches QIAcuityDx digital PCR system for clinical testing in oncology
|
| Sep 27 |
Those who invested in Qiagen (NYSE:QGEN) five years ago are up 41%
|
| Sep 27 |
Qiagen secures EU IVDR certification for QIAstat-Dx systems and panels
|
| Sep 27 |
QGEN Stock to Gain From New IVDR Win for QIAstat-Dx Systems and Panels
|
| Sep 26 |
QIAGEN receives European IVDR certification for QIAstat-Dx syndromic testing instruments and assays
|
| Sep 26 |
QIAGEN Stock Likely to Gain From PreAnalytiX's Newly Launched PAXgene
|
| Sep 26 |
PreAnalytiX introduces urine liquid biopsy solution
|
| Sep 25 |
PreAnalytiX, a QIAGEN and BD joint venture, launches novel solution for liquid biopsy from urine samples
|
